Table 3 Logistic regression analysis for predictors of recurrence / distant metastasis
Variable | Recurrence/distant metastasis | |||
|---|---|---|---|---|
Univariate | Multivariate | |||
p-value | Crude OR(95% CI) | p-value | AORa (95% CI) | |
Age | 0.2 | 0.98 (0.96–1.01) | 0.4 | 0.99 (0.06–6.97) |
Sex | 0.7 | 1.2 (0.6–2.4) | - | - |
Smoking | 0.4 | 1.4 (0.69–2.84) | - | - |
Alcohol | 0.8 | 1.2 (0.55–2.26) | - | - |
Family history | 0.2 | 1.63 (0.78–3.46) | - | - |
MSI: Loss-Intact | 0.5 | 1.56 (0.39–6.15) | - | - |
Mucinous histology | 0.6 | 0.76 (0.39–1.99) | - | - |
Signet ring | 0.9 | 0.96 (0.08–10.95) | - | - |
Tumor size | 0.1 | 1.1 (0.98–1.26) | - | - |
Lymph node status | 0.03* | 0.42 (0.19–0.91) | 0.3 | 0.59 (0.24–1.49) |
No. of lymph nodes | 0.5 | 1.03 (0.94–1.14) | - | - |
No. of LN extracted | 0.4 | 0.95 (0.94–1.02) | - | - |
No. of tumor deposits | 0.04* | 1.17 (1.007–1.37) | 0.04* | 1.17 (1.001–1.37) |
LVI | 0.07 | 2.18 (0.94–5.08) | - | - |
PNI | 0.9 | 1.04 (0.5–2.15) | - | - |
Adjuvant therapy | 0.02* | 2.68 (1.22–5.92) | 0.1 | 2.01 (0.79–5.12) |